BPC
CLMT icon

Bryce Point Capital’s Calumet Specialty Products CLMT Stock Holding History

Bryce Point Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,696
Closed -$228K – 196
2025
Q1 		$228K Buy
+18,696
New +$294K 0.17% 160

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return

Bryce Point Capital's CLMT Position: Q2 2025 in Review

Bryce Point Capital sold out of Calumet Specialty Products (CLMT) in Q2 2025, closing a stake of 18,696 shares — an estimated $228K sold.

Bryce Point Capital first reported a position in CLMT in Q1 2025 and held it in 1 quarter. The position peaked at $228K in Q1 2025. 134 funds tracked by Wall St. Rank hold CLMT as of Q2 2025.

  • Bryce Point Capital reported no remaining Calumet Specialty Products position as of Q2 2025 after selling out during the quarter.
  • Bryce Point Capital sold 18,696 Calumet Specialty Products shares in Q2 2025, an estimated $228K.
  • Bryce Point Capital first reported a position in Calumet Specialty Products in Q1 2025 and held it in 1 quarter.
  • Bryce Point Capital's Calumet Specialty Products position peaked at $228K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2025.

Based on Bryce Point Capital's 13F filing for Q2 2025, filed 5 Aug 2025.